Thompson Rubinstein Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $529K | Hold |
8,295
| – | – | 0.17% | 65 |
|
|
2018
Q4 | $424K | Hold |
8,295
| – | – | 0.16% | 66 |
|
|
2018
Q3 | $481K | Sell |
8,295
-423
| -5% | -$24.5K | 0.15% | 68 |
|
|
2018
Q2 | $423K | Hold |
8,718
| – | – | 0.14% | 69 |
|
|
2018
Q1 | $405K | Hold |
8,718
| – | – | 0.14% | 69 |
|
|
2017
Q4 | $328K | Hold |
8,718
| – | – | 0.11% | 74 |
|
|
2017
Q3 | $318K | Sell |
8,718
-912
| -9% | -$33.3K | 0.11% | 75 |
|
|
2017
Q2 | $380K | Sell |
9,630
-2,400
| -20% | -$94.7K | 0.14% | 73 |
|
|
2017
Q1 | $377K | Hold |
12,030
| – | – | 0.14% | 71 |
|
|
2016
Q4 | $376K | Hold |
12,030
| – | – | 0.14% | 69 |
|
|
2016
Q3 | $483K | Hold |
12,030
| – | – | 0.18% | 66 |
|
|
2016
Q2 | $400K | Hold |
12,030
| – | – | 0.16% | 70 |
|
|
2016
Q1 | $354K | Hold |
12,030
| – | – | 0.14% | 70 |
|
|
2015
Q4 | $317K | Hold |
12,030
| – | – | 0.15% | 69 |
|
|
2015
Q3 | $285K | Hold |
12,030
| – | – | 0.13% | 68 |
|
|
2015
Q2 | $286K | Hold |
12,030
| – | – | 0.11% | 71 |
|
|
2015
Q1 | $286K | Sell |
12,030
-41,238
| -77% | -$980K | 0.11% | 69 |
|
|
2014
Q4 | $1.13M | Sell |
53,268
-271,482
| -84% | -$5.76M | 0.43% | 54 |
|
|
2014
Q3 | $5.53M | Sell |
324,750
-39,810
| -11% | -$678K | 2.18% | 18 |
|
|
2014
Q2 | $5.22M | Hold |
364,560
| – | – | 1.97% | 18 |
|
|
2014
Q1 | $4.51M | Buy |
364,560
+14,046
| +4% | +$174K | 1.8% | 22 |
|
|
2013
Q4 | $3.84M | Buy |
350,514
+331,884
| +1,781% | +$3.64M | 1.51% | 28 |
|
|
2013
Q3 | $216K | Buy |
+18,630
| New | +$216K | 0.09% | 67 |
|